Aimei Health Technology (AFJK) Preferred Stock Liabilities (2023 - 2025)

Aimei Health Technology (AFJK) has 3 years of Preferred Stock Liabilities data on file, last reported at $45.4 million in Q3 2025.

• Preferred Stock Liabilities for Q3 2025 came in at $45.4 million, down 37.46% year-over-year; the trailing twelve-month figure through Sep 2025 was $45.4 million (down 37.46% YoY), and the FY2024 annual result was $73.8 million, up 5.57% from the prior year.
• Preferred Stock Liabilities climbed to $45.4 million in Q3 2025 per AFJK's latest filing, from $44.5 million in the prior quarter.
• Over five years, Preferred Stock Liabilities peaked at $73.8 million in Q4 2024 and troughed at $43.6 million in Q1 2025.
• A 3-year average of $61.6 million and a median of $70.3 million in 2023 frame the typical range for Preferred Stock Liabilities.
• The sharpest annual moves came in 2024 and 2025: Preferred Stock Liabilities climbed 5.57% in 2024, then sank 38.42% in 2025.
• A 3-year view of Preferred Stock Liabilities shows it stood at $69.9 million in 2023, then grew by 5.57% to $73.8 million in 2024, then tumbled by 38.41% to $45.4 million in 2025.
• Business Quant data shows AFJK's Preferred Stock Liabilities at $45.4 million in Q3 2025, $44.5 million in Q2 2025, and $43.6 million in Q1 2025.